LifeSciencePLUS, Inc., is pleased to announce that BloodSTOP® has been granted the Class IIb CE Mark certification for the control of bleeding from all surface wounds. “We are pleased to be able to extend our markets for this breakthrough product beyond the US and into the European markets,” said Vicky Feng, President and CEO.
Recent Posts
- LifeScience PLUS Secures FDA 510(k) Clearance for BloodSTOP® iX Trauma Matrix for Severe Bleeding Control
- Potential New Application for BloodSTOP® iX in Neurosurgical CSF Leakage Management
- Jacobi Burn Center Highlights Clinical Success with BloodSTOP iX at ABA Annual Meeting
- LifeScience PLUS Announces Publication on Revolutionary eCMC Technology in The Journal of Burn Care and Research
- America’s Lifeblood is in Crisis: A Novel Hemostatic Dressing Provides Hope